BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Samsung Biologics Reports KRW 1.49 Trillion Q3 Revenue as Global Manufacturing Expansion Drives Growth

Recorded Q3'26 revenue of KRW 1,490 billion and operating profit of KRW 640 billion Plant 5 ramp-up and U.S. manufacturing operations contribute to earn...

October 23, 2026 | Company results

What Eight APAC Regulators Have Actually Published on AI in Drug Development

Ask a regulatory affairs lead in Tokyo, Seoul or Singapore what the rules are for using a machine learning model in a drug submission, and the honest answe...

October 22, 2026 | Analysis

Cotecna Accelerates India Life Sciences Expansion With Acquisition of Hyderabad-Based Energon Labs

Cotecna, a leading provider of Testing, Inspection and Certification (TIC) services, announced the acquisition of Energon Labs, a cGMP-compliant, USF...

October 20, 2026 | News

How Long It Takes to Start a Clinical Trial in 8 APAC Markets, Timed

If you are building a 2027 trial budget this month, you are probably working from a spreadsheet with one row per country and a column headed "start-up". Mo...

October 19, 2026 | News

Semaglutide Generics, Six Months In: Every Launch in India, Every Price, and Where China Stands

AT A GLANCE 12 generic makers with a public launch in India, selling 20 brands between them Rs 1,290 lowest stated monthly price, for vials...

October 09, 2026 | Analysis

Piramal and NP2 Advance Generic Cancer Drug Cyclophosphamide Towards US Manufacturing

Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturi...

October 02, 2026 | News

Piramal Pharma Invests $5.3M to Expand Drug Substance Manufacturing in Canada

Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure. With its investment throug...

October 01, 2026 | Analysis

Tech Mahindra, Verato Partner to Strengthen Data Foundations for AI-Driven Healthcare

The partnership gives U.S. health systems, payers, pharma, and device makers a trusted way to match patient, provider, and member records as they modernize...

September 25, 2026 | News

Merck Life Science Expands Bengaluru Manufacturing with €13 Million Investment

Merck Life Science is expanding its manufacturing capabilities in Bengaluru with an investment of approximately €13 million, strengthening the company...

September 24, 2026 | News

Novonesis Invests €600M to Expand Enzyme Production Facility in India

Novonesis will expand its facility in Patalganga and build one of the world's most advanced enzyme production facilities. The €600 million investment ...

September 07, 2026 | News

Biocon Partners with Innomar Strategies to Strengthen Canada Supply Chain

Biocon has partnered with Innomar Strategies, a healthcare services and logistics company, to strengthen its pharmaceutical supply chain and distribution n...

August 25, 2026 | News

Piramal Pharma Acquires Majority Stake in Yapan Bio to Strengthen Biologics CDMO Capabilities

Yapan Bio Private Limited specializes in process development, characterization, and phase I and II GMP manufacturing services for vaccines and biologics....

August 20, 2026 | News

Biocon Launches Interchangeable YESAFILI Biosimilar to EYLEA in the U.S.

Yesafili™ (aflibercept-jbvf) now available in the United States as an U.S. FDA-approved interchangeable biosimilar to EYLEA 2 mg Potential ...

August 06, 2026 | News

Enzene Launches NeX™ to Enable Local Biologics Manufacturing Worldwide

Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO™), announced the launch of NeX™, a transform...

August 05, 2026 | News

Stay Connected